These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2843743)
21. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart. Temma K; Akera T J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640 [TBL] [Abstract][Full Text] [Related]
22. Consequences of mutations to the phosphorylation site of the alpha-subunit of Na, K-ATPase for ATP binding and E1-E2 conformational equilibrium. Pedersen PA; Rasmussen JH; Jørgensen PL Biochemistry; 1996 Dec; 35(50):16085-93. PubMed ID: 8973179 [TBL] [Abstract][Full Text] [Related]
23. Evidence for the binding of beta-adrenoceptor blockers to microsomal Na+/K+-ATPase in guinea pig heart preparations. Almotrefi AA; Basco C; Moorji A; Dzimiri N Can J Physiol Pharmacol; 2001 Jan; 79(1):8-12. PubMed ID: 11201505 [TBL] [Abstract][Full Text] [Related]
24. Characterization of ouabain receptor in neuronal tissue: evidence for endogenous ouabain-like compound. Lichtstein D; Samuelov S Isr J Med Sci; 1982 Jan; 18(1):45-50. PubMed ID: 6121774 [TBL] [Abstract][Full Text] [Related]
25. Class I antiarrhythmic drug effects on ouabain binding to guinea pig cardiac Na+ -K+ ATPase. Almotrefi AA; Basco C; Moorji A; Dzimiri N Can J Physiol Pharmacol; 1999 Nov; 77(11):866-70. PubMed ID: 10593659 [TBL] [Abstract][Full Text] [Related]
26. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 1: experimental studies. Ferrandi M; Molinari I; Torielli L; Padoani G; Salardi S; Rastaldi MP; Ferrari P; Bianchi G Sci Transl Med; 2010 Nov; 2(59):59ra86. PubMed ID: 21106940 [TBL] [Abstract][Full Text] [Related]
27. Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders. Goldstein I; Levy T; Galili D; Ovadia H; Yirmiya R; Rosen H; Lichtstein D Biol Psychiatry; 2006 Sep; 60(5):491-9. PubMed ID: 16712803 [TBL] [Abstract][Full Text] [Related]
28. Mutant Phe788 --> Leu of the Na+,K+-ATPase is inhibited by micromolar concentrations of potassium and exhibits high Na+-ATPase activity at low sodium concentrations. Vilsen B Biochemistry; 1999 Aug; 38(35):11389-400. PubMed ID: 10471289 [TBL] [Abstract][Full Text] [Related]
29. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations. Coughlin RT; Akera T; McGroarty EJ; Steinbach C Mol Pharmacol; 1987 Jul; 32(1):147-53. PubMed ID: 3037299 [TBL] [Abstract][Full Text] [Related]
30. Spironolactone- and canrenone-induced changes in hepatic (Na+,K+)ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat. Miner PB; Sneller M; Crawford SS Hepatology; 1983; 3(4):481-8. PubMed ID: 6305816 [TBL] [Abstract][Full Text] [Related]
31. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells. Gentile DA; Skoner DP Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446 [TBL] [Abstract][Full Text] [Related]
32. Evidence for tryptophan residues in the cation transport path of the Na(+),K(+)-ATPase. Yudowski GA; Bar Shimon M; Tal DM; González-Lebrero RM; Rossi RC; Garrahan PJ; Beaugé LA; Karlish SJ Biochemistry; 2003 Sep; 42(34):10212-22. PubMed ID: 12939149 [TBL] [Abstract][Full Text] [Related]
33. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844 [TBL] [Abstract][Full Text] [Related]
34. Ouabain binding to brain (Na+,K+)-adenosine triphosphatase: interactions of K+, ethanol and norepinephrine with high- and low-affinity binding. Swann AC J Pharmacol Exp Ther; 1987 Jan; 240(1):187-95. PubMed ID: 3027303 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic response to canrenone of patients with essential hypertension as a function of sodium transport anomalies and ouabain sensitivity of erythrocytes]. Hannaert P; Laurent S; Girerd X; Safar M; Abitbol JP; Garay R Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1603-7. PubMed ID: 2554840 [TBL] [Abstract][Full Text] [Related]
36. Functional consequences of substitutions of the carboxyl residue glutamate 779 of the Na,K-ATPase. Feng J; Lingrel JB Cell Mol Biol Res; 1995; 41(1):29-37. PubMed ID: 7550450 [TBL] [Abstract][Full Text] [Related]
37. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase. Brown L; Erdmann E; Thomas R Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008 [TBL] [Abstract][Full Text] [Related]
38. Involvement of natriuretic hormones and Na+ transport in the antihypertensive action of canrenone. Hannaert P; de Mendonca M; Grichois ML; Nazaret C; Abitbol JP; Garay R Uremia Invest; 1985-1986; 9(2):195-201. PubMed ID: 2429426 [TBL] [Abstract][Full Text] [Related]
39. Glutamic acid 327 in the sheep alpha 1 isoform of Na+,K(+)-ATPase is a pivotal residue for cation-induced conformational changes. Johnson CL; Kuntzweiler TA; Lingrel JB; Johnson CG; Wallick ET Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):187-94. PubMed ID: 7619055 [TBL] [Abstract][Full Text] [Related]
40. Erythrocyte Na+, K+ pump inhibition after saline infusion in essentially hypertensive subjects: effects of canrenone administration. Boero R; Guarena C; Deabate MC; Rolando B; Rosati C; Quarello F; Piccoli G Int J Cardiol; 1989; 25 Suppl 1():S47-52. PubMed ID: 2620996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]